- I'm thrilled that we are now able to meet partners and customers in person again. Vitafoods is an excellent show for us and for our newly established network of European distributors. We are here together with all the leading players in the growing field of nutraceuticals and I'm looking forward to present aXivite and the documented benefits of our commercially ready and approved product, says Lucas Altepost, Vice President and VP Sales and Marketing at aXichem.
About aXivite and the clinical trial "Effects of Phenyl-Capsaicin on Weight Loss and Body Composition":
aXivite (phenylcapsaicin) is a novel functional ingredient derived from the natural compound, capsaicin. In a recently completed healthy human, blinded, randomized, clinical study, aXivite demonstrated statistically significant body fat loss, an improved body-shape and lean mass profile and improved gut health, as measured by a decrease in serum zonulin. At both the low and high dose tested, aXivite showed excellent tolerability and safety profile over the 8 week treatment period.
The eight-week study was conducted as a randomized, double-blind, parallel-group clinical trial of male and female subjects recruited at a single investigational center in
aXivite is a well-studied synthetic capsaicin which is being developed for multiple nutraceutical and pharmaceutical applications. aXivite's gut-health mechanism of action is particularly associated with reduced inflammation, occurring via a statistically significant reduction in serum zonulin levels. This clinical study has demonstrated a metabolic role for aXivite that induces increased fat-burn leading to healthy weight loss and body shape in healthy subjects. Unpublished and published data with aXivite treatment, including this clinical study, continue to demonstrate an excellent safety and tolerability profile at both high (1,12 mg/day) and low (0,560mg/day) doses.
About Vitafoods Europe:
Vitafoods Europe started 1997 to meet the growing demands of the emerging nutraceutical industry. CEO and Founder,
This press release was submitted by the contact person below on
aXichem's business idea is to develop, patent and market natural analogue industrial compounds. The Company primarily works with phenylcapsaicin a structural analogue of capsaicin with a wide range of applications, such as feed additives, marine anti-fouling products and certain pharmaceutical areas. aXichem's shares are listed on NASDAQ First North Growth Market under AXIC A. Certified Adviser: Redeye AB Certifiedadviser@redeye.se +46 (0)8 121 576 90. Read more about the company at www.axichem.se
https://news.cision.com/axichem-ab/r/axichem-exhibits-at-vitafoods-europe-2021-in-geneva--presenting-its-innovative-product-axivite--with,c3413688
https://mb.cision.com/Main/8586/3413688/1467159.pdf
(c) 2021 Cision. All rights reserved., source